Article Details
Retrieved on: 2024-02-27 19:31:31
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the FDA's draft guidance under Project Optimus, highlighting the shift in oncology drug development towards patient-centric approaches and the use of AI, like ChatGPT, to improve the efficiency of clinical trials for biopharmaceuticals, including targeted therapies like trastuzumab.
Article found on: www.appliedclinicaltrialsonline.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here